GCA Advised Telemos Capital on the Acquisition Financing for the Newly Founded Sanoptis

GCA advised Telemos Capital on the acquisition financing for the newly founded Sanoptis group, a European ophthalmology services group comprising 53 facilities in Germany and Switzerland. The financing structure provides Sanoptis with a favorable basis to pursue its ambitious buy-and-build strategy.

Sanoptis offers the full spectrum of diagnostic and surgical ophthalmic treatments, including cataract operations and intravitreal injections for age-related macular degeneration. With over 500 employees, the Sanoptis group performed over 300,000 diagnostic consultations and more than 50,000 surgical procedures in 2018. The group comprises two ophthalmology hospitals in Germany and 51 outpatient facilities across Germany and Switzerland.

Sanoptis was established by Telemos Capital. Funded by family capital, Telemos Capital invests in private European businesses with the aim of building great, stable companies by combining the flexibility and nimble decision making of a family office with the active ownership and professionalism of private equity.

Sanoptis has partnered with leading ophthalmologists who have demonstrated a long track record of clinical excellence and successfully developed their respective clinic groups into regional market leaders.

GCA advised Telemos on a tailored financing package that supports the successful buy-and-build approach of the group while considering Sanoptis’ partnerships with ophthalmologists on a regional basis. Dr Volker Wendel, CEO of Sanoptis explained: “The new financing structure will give us both the required flexibility and the funding security to execute our exciting organic and inorganic growth strategy.”